Christian Kowol

Associate Professor

Universität Wien

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christian Kowol is an Associate Professor at the University of Vienna, Austria. His recent research focuses on cancer drug resistance, including the development of oxaliplatin-based prodrugs and novel linkers for drug targeting. He also investigates the structure-activity relationships of albumin-targeted drugs and the impact of mycotoxins on cancer treatments.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Michael Jakupec

Universität Wien

AUSTRIA

View details

Éva A. Enyedy

University of Szeged

HUNGARY

View details

Andreia Valente

Universidade de Aveiro

PORTUGAL

View details

Alexander Kastner

Universität Wien

AUSTRIA

View details

Gunda Koellensperger

Professor

AUSTRIA

View details

Bernhard K. Keppler

AUSTRIA

View details

Thomas Mindt

Universität Wien

AUSTRIA

View details

Dominik Wenisch

Universität Wien

AUSTRIA

View details

Melinda Rezeli

SWEDEN

View details

Walter Berger

AUSTRIA

View details

Manfred Ogris

Universität Wien

AUSTRIA

View details

Michael Grusch

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christian Kowol

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Schiff bases and cancer drug resistance: key preclinical breakthroughs

Comparative Evaluation of Thiol- and Amine-Conjugating Moieties for Endogenous Albumin Binding after Intravenous Administration

Site-Selectively Functionalized Albumin with DFO*Maleimide for 89Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice

Novel Maleimide Linkers Based on a Piperazine Motif for Strongly Increased Aqueous Solubility

Exploring the Structure–Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) Prodrugs

Opposing effects of mycotoxins alternariol and deoxynivalenol on the immunomodulatory effects of oxaliplatin and triapine

A new fluorescent oxaliplatin(IV) complex with EGFR-inhibiting properties for the treatment of drug-resistant cancer cells

Albumin-targeted oxaliplatin(IV) prodrugs bearing STING agonists

Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer

The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: Role of protonation-dependent crystallization processes

Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands

Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo

Entinostat enhances the efficacy of chemotherapy in small cell lung cancer through S-phase arrest and decreased base excision repair

Multi-action platinum(IV) prodrugs conjugated with COX-inhibiting NSAIDs

Human serum albumin as a copper source for anticancer thiosemicarbazones

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance

Oxoplatin‐Based Pt(IV) Lipoate Complexes and Their Biological Activity

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance

Collaborators (12)

Michael Jakupec

Éva A. Enyedy

Andreia Valente

Alexander Kastner

Gunda Koellensperger

Bernhard K. Keppler

Thomas Mindt

Dominik Wenisch

Melinda Rezeli

Walter Berger

Manfred Ogris

Michael Grusch

Make your next move.